BMO
HOLX

Beck Mack & Oliver’s Hologic HOLX Stock Holding History

Beck Mack & Oliver’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,600
Closed -$209K – 238
2017
Q2 		$209K Buy
+4,600
New +$203K 0.01% 221
2013
Q3 		– Sell
-10,600
Closed -$205K – 357
2013
Q2 		$205K Buy
+10,600
New +$221K 0.01% 329

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Beck Mack & Oliver's HOLX Position: Q3 2017 in Review

Beck Mack & Oliver sold out of Hologic (HOLX) in Q3 2017, closing a stake of 4,600 shares — an estimated $209K sold.

Beck Mack & Oliver first reported a position in HOLX in Q2 2013 and held it in 2 quarters. The position peaked at $209K in Q2 2017. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

  • Beck Mack & Oliver reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
  • Beck Mack & Oliver sold 4,600 Hologic shares in Q3 2017, an estimated $209K.
  • Beck Mack & Oliver first reported a position in Hologic in Q2 2013 and held it in 2 quarters.
  • Beck Mack & Oliver's Hologic position peaked at $209K in Q2 2017.
  • 457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Beck Mack & Oliver's 13F filing for Q3 2017, filed 27 Oct 2017.